The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX
Open accessAbstract
Inactivating mutations of Phex cause X-linked hypophosphatemia (XLH) by increasing levels of a circulating phosphaturic factor. FGF23 is a candidate for this phosphaturic factor. Elevated serum FGF23 levels correlate with the degree of hypophosphatemia in XLH, suggesting that loss of Phex function in this disorder results in either diminished degradation and/or increased biosynthesis of FGF23. To establish the mechanisms whereby Phex regulates FGF23, we assessed Phex-dependent hydrolysis of recombinant FGF23 in vitro and measured fgf23 message levels in the Hyp mouse homologue of XLH. In COS-7 cells, overexpression of FGF23 resulted in its degradation into N- and C-terminal fragments by an endogenous decanoyl-Arg-Val-Lys-Arg-chloromethyl ketone-sensitive furin-type convertase. Phex-dependent hydrolysis of full-length FGF23 or its N- and C-terminal fragments could not be demonstrated in the presence or absence of decanoyl-Arg-Val-Lys-Arg-chloromethyl ketone in COS-7 cells expressing Phex and FGF23. In a reticulolysate system, apparent cleavage of FGF23 occurred with wild-type Phex, the inactive Phex-3'M mutant, and vector controls, indicating nonspecific metabolism of FGF23 by contaminating enzymes. These findings suggest that FGF23 is not a direct Phex substrate. In contrast, by real-time reverse transcriptase PCR, the levels of fgf23 transcripts were highest in bone, the predominant site of Phex expression. In addition, Hyp mice displayed a bone-restricted increase in fgf23 transcripts in association with inactivating Phex mutations. Increased expression of fgf23 was also observed in Hyp-derived osteoblasts in culture. These findings suggest that Phex, possibly through the actions of unidentified Phex substrates or other downstream effectors, regulates fgf23 expression as part of a potential hormonal axis between bone and kidney that controls systemic phosphate homeostasis and mineralization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K. E., Evans, W. E., O'Riordan, J. L. H., Speer, M. C., Econs, M. J., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. M. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,528
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101545198 · Cited by 1,457
Francis, F., Hennig, S., Korn, B., Reinhardt, R., de Jong, P., Poustka, A., Lehrach, H., Rowe, P. S. N., Goulding, J. N., Summerfield, T., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-130 · Cited by 1,107
Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia
Jonsson, K. B., Zahradnik, R., Larsson, T., White, K. E., Sugimoto, T., Imanishi, Y., Yamamoto, T., Hampson, G., Koshiyama, H., Ljunggren, Ö., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020881 · Cited by 914
NAKAYAMA, K. (1997) · Biochemical Journal · doi:10.1042/bj3270625 · Cited by 789
Yamazaki, Y., Okazaki, R., Shibata, M., Hasegawa, Y., Satoh, K., Tajima, T., Takeuchi, Y., Fujita, T., Nakahara, K., Yamashita, T., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021105 · Cited by 671
Yamashita, T., Yoshioka, M., & Itoh, N. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3696 · Cited by 554
Emoto, N., & Yanagisawa, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15262 · Cited by 499
Shimada, T. (2002) · Endocrinology · doi:10.1210/en.143.8.3179 · Cited by 446
Saito, H., Kusano, K., Kinosaki, M., Ito, H., Hirata, M., Segawa, H., Miyamoto, K.-I., & Fukushima, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207872200 · Cited by 414
Serum FGF23 Levels in Normal and Disordered Phosphorus Homeostasis
Weber, T. J., Liu, S., Indridason, O. S., & Quarles, L. D. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.7.1227 · Cited by 354
Self-citationFGF-23 Inhibits Renal Tubular Phosphate Transport and Is a PHEX Substrate
Bowe, A. E., Finnegan, R., Jan de Beur, S. M., Cho, J., Levine, M. A., Kumar, R., & Schiavi, S. C. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5084 · Cited by 344
White, K. E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.497 · Cited by 329
Beck, L., Soumounou, Y., Martel, J., Krishnamurthy, G., Gauthier, C., Goodyer, C. G., & Tenenhouse, H. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119276 · Cited by 290
Oefner, C., D’Arcy, A., Hennig, M., Winkler, F. K., & Dale, G. E. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3492 · Cited by 280
Bai, X.-Y., Miao, D., Goltzman, D., & Karaplis, A. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210490200 · Cited by 276
Tumor-Induced Osteomalacia -- Unveiling a New Hormone
Econs, M. J., & Drezner, M. K. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302310 · Cited by 226
Nesbitt, T., Coffman, T. M., Griffiths, R., & Drezner, M. K. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115735 · Cited by 219
Tumors Associated With Oncogenic Osteomalacia Express Genes Important in Bone and Mineral Metabolism
De Beur, S. M. J., Finnegan, R. B., Vassiliadis, J., Cook, B., Barberio, D., Estes, S., Manavalan, P., Petroziello, J., Madden, S. L., Cho, J. Y., et al. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.1102 · Cited by 212
Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice
Dr. Meyer, R. A., Meyer, M. H., & Gray, R. W. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040407 · Cited by 209
Pex Gene Deletions in Gy and Hyp Mice Provide Mouse Models for X-Linked Hypophosphatemia
Strom, T. M., Francis, F., Lorenz, B., Boddrich, A., Lehrach, H., Econs, M. J., & Meitinger, T. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.2.165 · Cited by 199
Du, L., Desbarats, M., Viel, J., Glorieux, F. H., Cawthorn, C., & Ecarot, B. (1996) · Genomics · doi:10.1006/geno.1996.0421 · Cited by 174
Smith, M. M., Shi, L., & Navre, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6440 · Cited by 162
Pex mRNA Is Localized in Developing Mouse Osteoblasts and Odontoblasts
Frota Ruchon, A., Marcinkiewicz, M., Siegfried, G., Tenenhouse, H. S., DesGroseillers, L., Crine, P., & Boileau, G. (1998) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549804600405 · Cited by 160
Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets.
Holm, I. A., Huang, X., & Kunkel, L. M. (1997) · PubMed · Cited by 155
Argiro, L., Desbarats, M., Glorieux, F. H., & Ecarot, B. (2001) · Genomics · doi:10.1006/geno.2001.6553 · Cited by 153
Ruchon, A. F., Tenenhouse, H. S., Marcinkiewicz, M. M., Siegfried, G., Aubin, J. E., DesGroseillers, L., Crine, P., & Boileau, G. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.8.1440 · Cited by 138
Lipman, M. L., Panda, D. K., Bennett, H. P. J., Henderson, J. E., Shane, E. J., Shen, Y., Goltzman, D., & Karaplis, A. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13729 · Cited by 134
Meyer, R. A., Meyer, M. H., Tenenhouse, H. S., & Klugerman, A. H. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040411 · Cited by 125
Inhibition of MEPE cleavage by Phex
Guo, R., Rowe, P. S., Liu, S., Simpson, L. G., Xiao, Z.-S., & Quarles, L. D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02125-3 · Cited by 120
Self-citationGuo, R., & Quarles, L. D. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.7.1009 · Cited by 108
Self-citationCampos, M., COUTURE, C., Hirata, I. Y., Juliano, M. A., Loisel, T. P., Crine, P., Juliano, L., Boileau, G., & Carmona, A. K. (2003) · Biochemical Journal · doi:10.1042/bj20030287 · Cited by 98
Ontogeny of Phex/PHEX Protein Expression in Mouse Embryo and Subcellular Localization in Osteoblasts
Thompson, D., Sabbagh, Y., Tenenhouse, H. S., Roche, P. C., Drezner, M. K., Salisbury, J. L., Grande, J. P., Poeschla, E. M., & Kumar, R. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.2.311 · Cited by 97
Valdenaire, O., Richards, J. G., Faull, R. L. M., & Schweizer, A. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00321-0 · Cited by 87
Boileau, G., Tenenhouse, H. S., DesGroseillers, L., & Crine, P. (2001) · Biochemical Journal · doi:10.1042/bj3550707 · Cited by 82
Analysis of recombinant Phex: an endopeptidase in search of a substrate
Guo, R., Liu, S., Spurney, R. F., & Quarles, L. D. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.4.e837 · Cited by 81
Self-citationFGF23, hypophosphatemia, and rickets: Has phosphatonin been found?
Strewler, G. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111154898 · Cited by 75
The Neprilysin Family in Health and Disease
Turner, A. J., Brown, C. D., Carson, J. A., & Barnes, K. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46826-3_25 · Cited by 71
Expression and Cloning of the Human X-Linked Hypophosphatemia Gene cDNA
Grieff, M., Mumm, S. R., Waeltz, P., Mazzarella, R. A., Whyte, M. P., Thakker, R. V., & Schlessinger, D. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6153 · Cited by 60
Nesbitt, T., Fujiwara, I., Thomas, R. F., Xiao, Z., Quarles, L. D., & Drezner, M. K. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.12.2027 · Cited by 53
Self-citationNtayi, C., Lorimier, S., Berthier‐Vergnes, O., Hornebeck, W., & Bernard, P. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5306 · Cited by 42
Cited by
The FGF family: biology, pathophysiology and therapy
Beenken, A., & Mohammadi, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2792 · Cited by 1,945
Regulation of Fibroblast Growth Factor-23 Signaling by Klotho
Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Baum, M. G., Schiavi, S., Hu, M.-C., Moe, O. W., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500457200 · Cited by 1,366
The Osteocyte: An Endocrine Cell … and More
Dallas, S. L., Prideaux, M., & Bonewald, L. F. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1026 · Cited by 1,042
FGF/FGFR signaling in health and disease
Xie, Y., Su, N., Yang, J., Tan, Q., Huang, S., Jin, M., Ni, Z., Zhang, B., Zhang, D., Luo, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00222-7 · Cited by 904
Fon Tacer, K., Bookout, A. L., Ding, X., Kurosu, H., John, G. B., Wang, L., Goetz, R., Mohammadi, M., Kuro-o, M., Mangelsdorf, D. J., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0142 · Cited by 700
Metadata
- Authors
- Liu, S., Guo, R., Simpson, L. G., Xiao, Z.-S., Burnham, C. E., & Quarles, L. D.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-09
- Volume
- 278
- Issue
- 39
- Pages
- 37419-37426
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2011349880
- Cited by
- 508
- References
- 41
- FWCI
- 15.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.